ID   SU3
AC   CVCL_RQ45
DR   Wikidata; Q54970768
RX   PubMed=22360855;
RX   PubMed=29390972;
CC   Group: Cancer stem cell line.
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=22360855; DOI=10.5732/cjc.011.10336;
RA   Wan Y., Fei X.-F., Wang Z.-M., Jiang D.-Y., Chen H.-C., Yang J., Shi L.,
RA   Huang Q.;
RT   "Expression of miR-125b in the new, highly invasive glioma stem cell
RT   and progenitor cell line SU3.";
RL   Chin. J. Cancer 31:207-214(2012).
//
RX   PubMed=29390972; DOI=10.1186/s12865-018-0246-z;
RA   Fei X.-F., Wang A., Wang D.-L., Meng X., Ma J.-W., Hong L., Qin R.-W.,
RA   Wang A.-D., Dong J., Huang Q., Wang Z.-M.;
RT   "Establishment of malignantly transformed dendritic cell line
RT   SU3-ihDCTC induced by glioma stem cells and study on its sensitivity
RT   to resveratrol.";
RL   BMC Immunol. 19:7.1-7.14(2018).
//